A Systems Approach to the Clinical Research Enterprise— (What?...Really?) Greg Koski, PhD, MD President and CEO Alliance for Clinical Research Excellence.

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

Effective Contract Management Planning
Research Administration Capacity Building in an Established Institution Presenter: M.M.Aboud, MD Director of Research and Publications, MUHAS.
Control and Accounting Information Systems
Enterprise Security A Framework For Tomorrow Christopher P. Buse, CPA, CISA, CISSP Chief Information Security Officer State of Minnesota.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
BIOTECH SUPPLY October 8-9, 2012 Crowne Plaza, Foster City, CA Tufts CSDD Global Clinical Supply Chain Market Study Mary Jo Lamberti, PhD Senior Project.
Pharmacists Responsibilities in Clinical Studies Mike R Sather, PhD Crystal L Harris, PharmD February 26, 2004.
Enterprise Architecture The Arkansas Approach. Key Areas What is enterprise architecture? Why is it important? How you can participate Current status.
OHIO OFFICE OF INFORMATION TECHNOLOGY. Even the agents are suffering…
Irish Health Research: Collaboration and Partnership HSE Regional Library & Information Health Research Seminar Dr. Steevens’ Hospital 11th February 2011.
Implementing a Quality Management System
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
Going “Pro” The Rise of Professionalism in Clinical Research and Pharmaceutical Medicine Greg Koski, PhD, MD, CPI Associate Professor of Anesthesia Harvard.
Series 2: Project Management Advanced Project Management for Behavioral Health Electronic Health Records (EHRs) 9/2013 From the CIHS Video Series “Ten.
EMERGING AND RE-EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE STOA - AVIESAN Workshop June 19th 2012, European Parliament, Bruxelles.
NASA Growth Strategy Cindy Bolt Group Vice President March 10, 2009.
Community Information Technology Engagement (CITE): Program Overview
Internal Auditing and Outsourcing
A Global Network for Clinical Research— Really? Greg Koski, PhD, MD, CPI (Honorary) Associate Professor of Anesthesia Harvard Medical School Senior Scientist.
WHERE WE ARE 22 member associations in 20 countries Over 4300 individual members who are responsible for risk management and/or insurance in their organisations.
Component 2: The Culture of Health Care Unit 3: Health Care Settings— The Places Where Care Is Delivered Lecture 3 This material was developed by Oregon.
by Joint Commission International (JCI)
History of Responsible Care® in the Gulf Alan J. Izzard Borouge VP Corporate HSE/ VC RC Committee.
The Institute of Internal Auditors
UNM and Health System Internal Audit Departments Internal Audit Department Orientation Manu Patel, Internal Audit Director Purvi Mody, Executive Director,
NCI Review of the Clinical Trials Process 6 th Annual National Forum on Biomedical Imaging in Oncology James H. Doroshow M.D. April 7, 2005 Bethesda, Maryland.
Compliance Issues for Medical Research at Healthcare Systems Jerry Castellano, Pharm.D., CIP Corporate Director Institutional Review Board Christiana Care.
Fourth Annual Medical Research Summit Concurrent Session 4.05 – Managing CROs and SMOs from a Compliance Perspective Michael SwiatochaAprill 23, 2004.
Roles and Responsibilities
Changes in the International Standards for the Professional Practice of Internal Auditing & Implications for Healthcare Organizations AHIA Northwest Regional.
An Integrated Control Framework & Control Objectives for Information Technology – An IT Governance Framework COSO and COBIT 4.0.
Committee of Sponsoring Organizations of The Treadway Commission Formed in 1985 to sponsor the National Commission on Fraudulent Financial Reporting “Internal.
Chapter 6 CRISIS MANAGEMENT. Introduction - Crisis: ◦is a situation that specifically involves a pharmaceutical product, medical device or activity with.
Conducting Compliance Assessments and Building Internal Controls In Pharmaceutical R&D Third Annual Medical Research Summit – Session 2.01 Michael Swiatocha.
5 th Annual International Business Research Forum Globalization of the Pharmaceutical Industry Implications to Information Technology Bruce Fadem March.
Technology Transfer Execution Framework. 2 © 2007 Electric Power Research Institute, Inc. All rights reserved. Relationship Between Your EPRI Value and.
Fundamentals I: Accounting Information Systems McGraw-Hill/Irwin Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved.
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Conducting Clinical Risk Assessments And Implementing Compliance Practices Jane L. Stratton Chiron Corporation VP/Associate General Counsel Chief Compliance.
1.less than 3 million. 2.less than 10 million. 3.over 23 million. 4.over 100 million. 5.Not sure In the U.S., the number of managers that rely on Information.
1 Further Development of Customs Riga, 26 November th Anniversary of the State Revenue Service of Latvia Kunio Mikuriya Secretary General elect.
About OMICS Group OMICS Group is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in.
Agenda for Session Compliance in Clinical Research
NEACS: CRO Perspective William Feher Vice President, Internal Audit and Chief Risk Officer October 27, 2015.
Transforming Clinical Practice Initiative (TCPI) An Overview Connie K
Tri-Party Arrangements: Considering All Perspectives Presented by, Max Reiboldt, CPA, President / CEO Coker Group 2015 New York Metro ASC Symposium October.
Foundations of Information Systems in Business. System ® System  A system is an interrelated set of business procedures used within one business unit.
About OMICS Group OMICS Group is an amalgamation of Open Access Publications and worldwide international science conferences and events. Established in.
The U. S. Health Care System Challenges, Opportunities and Solutions Fifth National HIPAA Summit Clinical Data Standards and the Creation of an Interconnected,
VA Central IRB K. Lynn Cates, MD Assistant Chief Research & Development Officer Office of Research & Development Department of Veterans Affairs September.
March 2008 – DRAFT 1 Electronic Health Record (EHR) Task Force Financial Analysis Isabelle de Zegher and Greg Stadler.
Sicherheitsaspekte beim Betrieb von IT-Systemen Christian Leichtfried, BDE Smart Energy IBM Austria December 2011.
November th FERCAP International Conference Nagasaki, Japan TransCelerate Overview.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
COBIT. The Control Objectives for Information and related Technology (COBIT) A set of best practices (framework) for information technology (IT) management.
Making Clinical Trials More Efficient Site Management Organization (SMO)
© 2009 AT&T Intellectual Property. All rights reserved. AT&T and the AT&T logo are trademarks of AT&T Intellectual Property. The Sustainable Business Mid-America.
References: Supply Chain Saves the World. Boston, MA: AMR Research (2006); Designing and Managing the Supply Chain – Concepts, Strategies and Case Studies;
© 2014 GS1 US ALL RIGHTS RESERVED Making a Difference 1.
The Information Professional’s Role in Product Safety
1/22/2015 A partnership/collaboration from Bayer through setting up and implementing a global FSP strategy on a local level Keith Francis, Strategic.
Building A Community of Trust to Transform Medicines Development
Introduction to TransCelerate
The MasterCard Foundation – Prophix story
2017 Health care Preparedness and Response Draft Capabilities
Introduction to TransCelerate
Strategic Boards Toolkit
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
An Enabling Business Environment and A Strategy and Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Presentation transcript:

A Systems Approach to the Clinical Research Enterprise— (What?...Really?) Greg Koski, PhD, MD President and CEO Alliance for Clinical Research Excellence and Safety

Drug Development Today— A Complex Ecosystem under Intense Environmental Pressure In a rapidly changing environment the ability to survive is determined by the ability to adapt!

“The drug development model has not fundamentally changed in more than 50 years, when the Kefauver- Harris Amendments of 1962 established the current standard for the clinical testing of investigational drugs”…. --Kenneth I. Kaitin, PhD Tufts CSDD Director

Change Management— It takes a crisis! “The current approach to drug development is inefficient, ineffective and unsustainable.” DIA Europe, 2010

From Silos to Network Systems

Fundamental Elements of an Enterprise System for Clinical Research Global Network of Accredited Sites and Professionally Certified Clinical Research Workforce Standardized Policies and Operational Procedures Integrated Supply Chain Logistics Shared Information Infrastructure and Quality Risk Management System Connectivity Interoperability High-Reliability Quality & Safety

Systems Thinking: The Global Air Transport System

Service Providers Sponsors Regulators Government Agencies Ethics Committees Patients and Healthcare Systems Patients and Healthcare Systems Inputs Test Articles Protocols Contracts Regulations Boundaries Logistics Finances Technologies Collaborations Patents Outputs Data Safety Quality Efficiency Approval Market Share Profitability Sustainability Respectability Better Health Quality of Life Productivity Development People R&D Team Operations Team Investigators Coordinators Monitors Auditors Technologists Data Managers Ethicists Regulators Patients/Families Physicians Administrators CROs and SMOs Optimize Clinical Trial Performance Optimize Clinical Trial Performance Research Sites and Networks Research Sites and Networks Processes Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up Trial Conduct Data Collection Data Analysis Quality Management Adverse Events Reporting Monitoring Auditing NDA Approval Marketing Advertising Manufacturing Distribution

Service Providers Sponsors Regulators Government Agencies Ethics Committees Patients and Healthcare Systems Patients and Healthcare Systems Inputs Test Articles Protocols Contracts Regulations Boundaries Logistics Finances Technologies Collaborations Patents People R&D Team Operations Team Investigators Coordinators Monitors Auditors Technologists Data Managers Ethicists Regulators Patients/Families Physicians Administrators Processes Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up Trial Conduct Data Collection Data Analysis Quality Management Adverse Events Reporting Monitoring Auditing NDA Approval Marketing Advertising Manufacturing Distribution CROs and SMOs Systems-Focused Clinical Research Enterprise Systems-Focused Clinical Research Enterprise Research Sites and Networks Research Sites and Networks Outputs Data Safety Quality Efficiency Approval Market Share Profitability Sustainability Respectability Better Health Quality of Life Productivity Development

Service Providers Sponsors Regulators Government Agencies Ethics Committees Patients and Healthcare Systems Patients and Healthcare Systems Inputs Test Articles Protocols Contracts Regulations Boundaries Logistics Finances Technologies Collaborations Patents People R&D Team Operations Team Investigators Coordinators Monitors Auditors Technologists Data Managers Ethicists Regulators Patients/Families Physicians Administrators CROs and SMOs Research Sites and Networks Research Sites and Networks Processes Development Pre-Clinical Protocol Development Regulatory Approval EC Approval Site Selection Study Start-up Trial Conduct Data Collection Data Analysis Quality Management Adverse Events Reporting Monitoring Auditing NDA Approval Marketing Advertising Manufacturing Distribution Outputs Data Safety Quality Efficiency Approval Market Share Profitability Sustainability Respectability Better Health Quality of Life Productivity Development

A non-profit multi-sector alliance of like- minded people and organizations working collaboratively in the public interest to build a shared global system for clinical research excellence—Accountable Research What is ACRES?

Initial projects are underway in each of four operational domains where critical processes for research sites, sponsors, CROs, regulatory authorities, ethics committees, and research subjects intersect to achieve "clean data” with greater efficiency, safety and interoperability -- at the points where change is most needed. ACRES Foundation Initiatives Executive Office

Recognizing and Rewarding Excellence Putting Standards and Metrics to Work to Promote Professionalism and Performance in Clinical Research Worldwide Site Accreditation Standards Initiative

“For too long, the industry has failed to recognize the importance and value of well-established, sustainable, high-performing research sites. They are a resource that we have undervalued. Now is the time for us to take a more systemic approach that promotes site productivity and sustainability…” --Briggs Morrison, MD Vice-President for Global Medicines Development and Chief Medical Officer, AstraZeneca Member of the ACRES Board of Directors Sites Matter!

The Harsh Reality of Clinical Research Sites Today 70% of clinical research sites never do more than one clinical trial in the business lifetime Fewer than half of sites meet enrollment goals and 10% never enroll a single subject Few sites have professionally trained and certified research personnel Many sites are still using paper records without EDC/CTMS Monitoring accounts for nearly one-third on clinical trial budgets Redundancy, delays, non-compliance, and poor quality are the norm rather than the exception

Elements of Effective Accreditation Appropriate Standards Must be meaningful Measurable metrics Multi-stakeholder Effective Processes Minimize burdens Maximize value Neutral third-party Independent Oversight Ensure integrity Evaluate effectiveness Global Accreditation “Recognition of Excellence”

Establish an efficient, effective and representative Project Steering Committee Engage critical stakeholders to champion efforts for site accreditation and workforce certification Convene broad-based Collaboration Summit (s) to refine Scope, Strategy and Structure Empower a Global Working Group for Standards and Process Development Develop and Implement necessary standards and agreements Pilot Test and feedback from stakeholders Refine standards and implementation through regional networks Evolving needs of Society and Stakeholders Public Trust Professionalism Quality Assurance Site Performance Risk Management Information Technology Sustainable system infrastructure to drive clinical research quality, safety and efficiency

Global Dynamic Accreditation Process Quality Enterprise Management Smart Monitoring Smart Auditing Site Director Study Coordinator(s) Operations Manager(s) Data Manager(s) Investigator(s) Informatics Specialist(s) Study Sites Personnel Facilities Administration Information Technology Quality Management Research Integrity Patient Engagement Personnel Facilities Administration and Finance Administration and Finance Information Technology Quality Management Nurses and Technicians Standards Global Site Network Information Systems CTMS Risk Monitors Risk Monitors Operations Dashboard Operations Dashboard Complianc e Monitor Complianc e Monitor Enrollment Manager Enrollment Manager EDC Enrollment Manager Enrollment Manager Healthcare Organizations Supply Chain Providers Industry Sponsors Pharmaceuticals Biotechnology Medical Devices Regulatory Oversight Agencies Universal Collaborative Interface Cloud-Based Enterprise Data Vault Secure Data Aggregation and Interchange API Integrated Technology Applications Intelligent Analytic Engines Federated Trust Framework Identity Management Secure Digital Transactions eCommerce Clinical Data Operational Data Safety Data Financial Data Metadata Library Data Services Data Services Electronic Health Data Patient Demographics Contract Research Organizations Ethics Review Boards Real-Time Pharmaco- vigilance Smart Financial Engine Site Management Organizations Integrated Logistics All rights reserved, Alliance for Clinical Research Excellence and Safety, 2015

ACRES Value Proposition Urgent Challenges – Education and training – Trial complexity – Site selection – Performance – Monitoring – Data management – Pharmacovigilance – Regulatory compliance – Delays and redundancy – Time to market – Ethical review – Misconduct – Public confidence – Economic pressures – Global disparities More effective application (redirection) of existing resources to build a sustainable, shared “system infrastructure” will provide a handsome return on investment, economically, scientifically and socially. Current estimates of waste due to inefficiency and redundancy in the clinical trials process is approximately 30% An effective system could realize annual savings in excess of $20 Billion

Implementation Strategy and Timeline Maturation and Consolidation New Standards and Metrics; New strategic alliances; Performance Excellence; Self-sustaining organization Establishment and Growth of the Network Site identification; education and training ; regional expansion; products and services delivery; ”modular growth” opportunities by adding existing networks Engaging Alliance Partners and Stakeholders Standards, Metrics, Processes; Guidelines; IT Integration; Education, Certification and Accreditation Criteria; Quality Assurance Phase Phase Phase

Committed to Systems Solutions for Accountable Research TM